Erschienen in:
01.01.2010 | Letter
Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine
verfasst von:
J. M. Nagel, U. Mansmann, K. Wegscheider, J. Röhmel
Erschienen in:
Diabetologia
|
Ausgabe 1/2010
Einloggen, um Zugang zu erhalten
Excerpt
To the Editor: Hemkens et al. [
1] studied the risk of malignant neoplasms and mortality in patients treated with human insulin or with one of three insulin analogues. In vitro experiments [
2] demonstrated a potential association of insulin analogues with an increased risk of malignancies. Epidemiological corroboration of the in vitro findings would have major implications for diabetic patients worldwide. …